https://journalibrr.com/index.php/IBRR/issue/feed International Blood Research & Reviews 2021-04-22T13:55:14+00:00 International Blood Research & Reviews contact@journalibrr.com Open Journal Systems <p style="text-align: justify;"><strong>International Blood Research &amp; Reviews (ISSN:&nbsp;2321–7219)</strong> aims to publish high quality papers (<a href="/index.php/IBRR/general-guideline-for-authors">Click here for Types of paper</a>) in all areas of ‘Blood related research’. The journal also encourages the submission of useful reports of negative results. This is a quality controlled,&nbsp;OPEN&nbsp;peer reviewed, open access INTERNATIONAL journal.</p> https://journalibrr.com/index.php/IBRR/article/view/30145 Anemia: Considerations for the Dental Practitioner 2021-04-22T13:55:14+00:00 Georges Aoun aoungeorges@yahoo.com Pamela Aoun Wissam Sharrouf Abbass El-Outa <p>Anemia is a condition of decreased red blood cell number or hemoglobin concentration, or of disturbance in their function, ultimately leading to decreased oxygen transport to tissues. Many factors and diseases may lead to anemia, with wide manifestations systemically as well as orally. Therefore, a sound understanding of this condition is essential for the dental practitioner, with emphasis on alerting signs, dental management and proper communication with patient’s physician.</p> 2021-03-01T00:00:00+00:00 ##submission.copyrightStatement## https://journalibrr.com/index.php/IBRR/article/view/30146 Which Strategy to Manage Severe Vaso-occlusive Crisis in Patients with Sickle Cell Disease in Countries with Limited Healthcare Capacities? 2021-04-22T13:55:12+00:00 Lydie Ocini Ngolet lngolet@yahoo.fr Chelsea Jayne Bango Peggy Mawandza Alexis Elira Dokekias <p>We evaluated the treatment of morphine by intravenous patient controlled analgesia versus intermittent subcutaneous routes on patients with sickle cell disease developing severe vaso-occlusivecrisis.</p> <p><strong>Objectives:</strong> The primary objective was to compare intravenous patient controlled analgesia (PCA) versus intermittent subcutaneous injection of morphine (SC) on sickle cell patients developing severe vaso-occlusive crisis during the first 24 hours of admission. The secondary objective was to assess the side effects of morphine in both regimens.</p> <p><strong>Methods:</strong> A randomized controlled trial of 77 patients in the PCA and 81 in the SC group was conducted at the Sickle Cell Center of Brazzaville in the Republic of Congo. Participants aged from</p> <p>15 to 45 years old with severe vaso-occlusive crisis were included in the study.</p> <p><strong>Results:</strong> Both regimens provided pain relief. However, a significant pain reduction was observed 30 minutes after the administration of morphine in the PCA group (P= 0.001). The mean scores in the PCA and SC regimens were respectively: 1.16±1.40 and 4.30±2.32. The total median dose of morphine administered in the PCA regimen was markedly lower: 24,6±4,16 mg versus 36.6±3.1 mg in the SC group (P=0.01). Morphine administered by PCA provided pain relief during 24 hours while intermittent severe pain was experienced in the SC group (P=0.014). Sedation score S2, S3 was significantly observed in the SC group (P&lt; 0.05).</p> 2021-03-09T00:00:00+00:00 ##submission.copyrightStatement##